- Omada Health is partnering with Intermountain Healthcare’s value-based care unit Castell in the virtual chronic care company’s first care delivery partnership with a major health system.
- The two are linking to offer virtual diabetes care and prevention to Intermountain’s primary care patients in its Utah medical group. Castell will help to target and enroll eligible patients with or at risk for diabetes, giving them the option to enroll in an Omada program, according to a recent release.
- Omada expects to reach “thousands” of known patients in the new partnership, CEO Sean Duffy told Healthcare Dive. Financial terms of the deal have not been disclosed.
Omada was founded in 2011 with the goal of targeting care for the tens of millions of adults with chronic care issues, including the 11% of the U.S. population with diabetes.
The company started selling diabetes care management to employers and health plans, but its clinical areas have grown to include hypertension and musculoskeletal issues. Now, with the new partnership, it’s branching out into integrated virtual care with health systems as well.
The extension comes as the pandemic prompted many health systems to accept virtual care. And, as macro forces like inflation and labor shortages continue to pressure operators, hospitals are expected to continue adopting digital tools to streamline operations and care delivery.
Omada’s diabetes programs link member support with intervention from health coaches and medical devices, like continuous glucose monitors, to track progress on metrics like A1C levels in real-time. They also include an individualized care plan that uses behavioral science to encourage patients to make beneficial lifestyle changes.
Intermountain and Omada had a relationship for more than six years before launching its new partnership at the end of 2022, Duffy said. He didn’t share a timeline for the deal, but said he is “looking forward to continuing this partnership to enroll as many patients as possible and keep them engaged for as long as they need.”
In February, Omada closed a $192 million Series E financing round, with Duffy telling Business Insider and other outlets that the company was gearing up for an IPO at the end of 2022. However, the public offering failed to materialize.